Jpmorgan Chase & CO Zoetis Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Zoetis Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,136,758 shares of ZTS stock, worth $360 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,136,758

Previous 2,916,539 26.74%

Holding current value

$360 Million

Previous $570 Million 38.9%

% of portfolio

0.03%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$162.24 - $194.42 $127 Million - $152 Million	-779,781 Reduced 26.74%	2,136,758 $348 Million
Q3 2024 Dec 26, 2024	BUY	$172.58 - $196.48 $44.7 Million - $50.9 Million	258,892 Added 9.74%	2,916,539 $570 Million
Q3 2024 Nov 08, 2024	SELL	$172.58 - $196.48 $27.3 Million - $31.1 Million	-158,344 Reduced 5.96%	2,499,303 $488 Million
Q2 2024 Dec 26, 2024	BUY	$145.54 - $178.83 $23 Million - $28.3 Million	158,344 Added 6.34%	2,657,647 $461 Million
Q2 2024 Aug 12, 2024	BUY	$145.54 - $178.83 $3.17 Million - $3.9 Million	21,794 Added 0.83%	2,657,647 $461 Million
Q1 2024 Dec 26, 2024	BUY	$165.67 - $199.94 $22.6 Million - $27.3 Million	136,550 Added 5.46%	2,635,853 $446 Million
Q1 2024 May 10, 2024	BUY	$165.67 - $199.94 $42.7 Million - $51.5 Million	257,716 Added 10.84%	2,635,853 $446 Million
Q4 2023 Dec 26, 2024	SELL	$151.44 - $200.09 $18.3 Million - $24.2 Million	-121,166 Reduced 4.85%	2,378,137 $469 Million
Q4 2023 Feb 12, 2024	BUY	$151.44 - $200.09 $8.94 Million - $11.8 Million	59,001 Added 2.54%	2,378,137 $469 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $25 Million - $28.8 Million	149,385 Added 6.88%	2,319,136 $403 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $166 Million - $192 Million	1,028,946 Added 90.19%	2,169,751 $374 Million
Q1 2023 May 18, 2023	BUY	$145.48 - $175.02 $31.9 Million - $38.4 Million	219,367 Added 23.81%	1,140,805 $190 Million
Q1 2023 May 11, 2023	SELL	$145.48 - $175.02 $84.1 Million - $101 Million	-578,059 Reduced 38.55%	921,438 $153 Million
Q4 2022 Feb 13, 2023	SELL	$131.14 - $157.47 $78.5 Million - $94.3 Million	-598,646 Reduced 28.53%	1,499,497 $220 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $31.5 Million - $38.8 Million	-212,638 Reduced 9.2%	2,098,143 $311 Million
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $115 Million - $147 Million	736,720 Added 46.8%	2,310,781 $397 Million
Q1 2022 May 11, 2022	BUY	$181.39 - $234.03 $54.3 Million - $70 Million	299,299 Added 23.48%	1,574,061 $297 Million
Q4 2021 Feb 10, 2022	BUY	$193.69 - $247.03 $14.4 Million - $18.3 Million	74,169 Added 6.18%	1,274,762 $311 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $227 Million - $252 Million	1,200,593 New	1,200,593 $233 Million

Others Institutions Holding ZTS

# of Institutions

2,053

Shares Held

419M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Zoetis Inc. Transaction History